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(BQF), was performed by the PTW QuickCheck webline 
(QCw). 20 x 20cm2 radiation field size and 99.3cm source to 
device surface distance was set on the Elekta Versa HD linear 
accelerator for the daily measurement. 6MV FF, 6MV FFF, 
10MV FF and 10MV FFF beams were measured for 23 days 
from July to September 2014. The performance of QCw was 
assessed by calibrated ionization chamber for FF beams in 
another study within the same department. Gafchromic films 
were used to verify the result on flatness and symmetry on 
FFF beams. 
Results: Both 6MV & 10MV showed similar trends of variation 
on CAX and BQF measurement on both FF & FFF beams. CAX 
had ± 0.8% variation on both FF and FFF beams; BQF had ± 
2.0% on FF beams and ± 3.0% variations on FFF beams from 
its average value. The bigger variation of BQF in FFF beams 
might be due to the energy detectors positions being not in 
line with the Central Axis detector in the QCw. The 
measurement has been verified by calibration ionization 
chamber. Flatness had±0.4% on FF and ± 0.6% deviation on 
FFF beams, Symmetry (GT) showed within ± 0.6% deviation of 
both FF and FFF beams, while Symmetry (LR) had variation 
from -0.5% to +1.2% from the average value.  
 
 
 
Conclusions: FFF beams had larger discrepancy on the 
symmetry measurement than other measurement when 
compared to FF beams. The FFF beams symmetry 
measurement is sensitive to positioning discrepancy, due to 
the larger gradient dose profile of FFF beams. Apart from 
that, QCw showed showed a good measurement agreement 
between FF and FFF beams. Therefore, lowering the dose 
rate of FFF beams is good enough for daily measurement with 
a constancy check device. 
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Purpose/Objective: This aim of this study was to evaluate 
the feasibility of standardized patient’s preparation protocol 
and treatment planning parameters on the plan’s quality for 
prostate cancer patients undergoing stereotactic body 
radiation therapy (SBRT) using non-isocentric CyberKnife (CK) 
technology. Treatment plans for prostate cancer patients 
undergoing SBRT are often challenging due to the proximity 
of organs at risk and also because there are no objective 
criteria to determine whether an optimal treatment plan has 
been achieved. 
Materials and Methods: 100 patients with clinically localized 
low-risk prostate cancer were treated with SBRT using CK. 
The prescription dose was 36,25 Gy in five fractions. The 
clinical target volume was defined as the prostate gland with 
5 mm added around and 3 mm posterioly for the planning 
target volume (PTV). Patient’s preparation: one day before 
computer tomography (CT) the pharmacotherapy with enema 
and anti – flatulence were done and thirty minutes before CT 
to fill the bladder patient drinks 400 ml of water. Treatment 
planning parameters: homogeneous prostate protocol, four 
Iris collimators with the size between 20 and 50 mm and 
InTempo imaging system. Plan’s quality was evaluated by PTV 
coverage, prescribed isodose, conformity index (CI), normal 
tissue sparing of rectum, bladder, urethra and testis. Total 
number of monitor units (MU) and the treatment delivery 
time were likewise to assess delivery efficiency. 
Results: For all cases: PTV coverage ≈ ≥ 95% (94.7 – 97.5%), 
prescribed isodose was 76 – 83%, CI was ranging between 1.04 
– 1.15 with the mean 1.10 ± 0.03. Mean values of MU’s 
number was equal to 34490 with range 29412-41911, 
treatment delivery time ≈ 31 min ranging between 24 – 38 
min. For whole group of patients all OAR’s constraints were 
achieved and the volumes of OARs were significantly lower 
then accepted in the protocol, the table 1 showed the OAR’s 
outcomes. 
Table 1. Doses for OARs for 100 prostate cancer patients 
undergoing SBRT with homogeneous protocol using CK 
technology 
 
 
Conclusions: These results suggest that SBRT for prostate 
cancer with CK needs standardization during preparation and 
planning stages of the treatment to facilitate the plan 
optimization process and to improve plan quality and 
consistency. Above planning constrains determining superior 
OAR’s doses to the accepted criteria in all cases. Addition 
benefit of using such the CK’s protocol for prostate is that 
the treatment planning process is less time consuming and 
treatment time is shorter.  
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